The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Abstract
The discovery of cisplatin's antitumor activity in 1969 prompted the search for novel metal-containing complexes as potential anticancer drugs. Among these novel complexes, metal N-heterocyclic carbene (NHC) complexes have recently gained considerable attention because they perfectly fit prerequisites for efficient drug design and fast optimization. Moreover, most of them have shown higher cytotoxicity than cisplatin. This review describes the advances that have been achieved in using transition metal (Ag, Au, Pt, Pd, Cu, Ni, and Ru) complexes containing NHC ligands as antitumor agents. Their modes of action at the cellular lever are further discussed. All these initial achievements clearly demonstrate the great potential of metal-NHC complexes as antitumor agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
Díez-González, S., Marion, N., & Nolan, S. P. (2009) · Chemical Reviews · doi:10.1021/cr900074m · Cited by 3,066
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Ruthenium-Based Heterocyclic Carbene-Coordinated Olefin Metathesis Catalysts
Vougioukalakis, G. C., & Grubbs, R. H. (2010) · Chemical Reviews · doi:10.1021/cr9002424 · Cited by 2,018
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Ag(I) N-Heterocyclic Carbene Complexes: Synthesis, Structure, and Application
Garrison, J. C., & Youngs, W. J. (2005) · Chemical Reviews · doi:10.1021/cr050004s · Cited by 1,091
Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 990
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Antitumour metal compounds: more than theme and variations
Jakupec, M. A., Galanski, M. S., Arion, V. B., Hartinger, C. G., & Keppler, B. K. (2008) · Dalton Transactions · doi:10.1039/b712656p · Cited by 850
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Copper Complexes as Anticancer Agents
Marzano, C., Pellei, M., Tisato, F., & Santini, C. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009787313837 · Cited by 802
Copper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Metal Complexes as DNA Intercalators
Liu, H.-K., & Sadler, P. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar100140e · Cited by 749
Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
Ray, S., Mohan, R., Singh, J. K., Samantaray, M. K., Shaikh, M. M., Panda, D., & Ghosh, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075889z · Cited by 656
Non Platinum Metal Complexes as Anti‐cancer Drugs
Ott, I., & Gust, R. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600151 · Cited by 609
Self-citationUsing coordination chemistry to design new medicines
Ronconi, L., & Sadler, P. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.11.017 · Cited by 608
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Bindoli, A., Rigobello, M. P., Scutari, G., Gabbiani, C., Casini, A., & Messori, L. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.026 · Cited by 595
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
van Rijt, S. H., & Sadler, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.003 · Cited by 592
The potential of organometallic complexes in medicinal chemistry
Gasser, G., & Metzler-Nolte, N. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.013 · Cited by 516
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Bergamo, A., & Sava, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01816c · Cited by 440
Boon and Bane of Metal Ions in Medicine
Thompson, K. H., & Orvig, C. (2003) · Science · doi:10.1126/science.1083004 · Cited by 424
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Organometallic ruthenium-based antitumor compounds with novel modes of action
Ang, W. H., Casini, A., Sava, G., & Dyson, P. J. (2011) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2010.11.009 · Cited by 366
Formation of Water-Soluble Pincer Silver(I)−Carbene Complexes: A Novel Antimicrobial Agent
Melaiye, A., Simons, R. S., Milsted, A., Pingitore, F., Wesdemiotis, C., Tessier, C. A., & Youngs, W. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030262m · Cited by 349
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Design of targeting ligands in medicinal inorganic chemistry
Storr, T., Thompson, K. H., & Orvig, C. (2006) · Chemical Society Reviews · doi:10.1039/b514859f · Cited by 326
Cyclam complexes and their applications in medicine
Liang, X., & Sadler, P. J. (2004) · Chemical Society Reviews · doi:10.1039/b313659k · Cited by 322
Silver and its application as an antimicrobial agent
Melaiye, A., & Youngs, W. J. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.2.125 · Cited by 289
Metals and metal compounds in cancer treatment.
Desoize, B. (2004) · PubMed · Cited by 276
Casini, A., Gabbiani, C., Sorrentino, F., Rigobello, M. P., Bindoli, A., Geldbach, T. J., Marrone, A., Re, N., Hartinger, C. G., Dyson, P. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006678 · Cited by 270
Barnard, P. J., Wedlock, L. E., Baker, M. V., Berners‐Price, S. J., Joyce, D. A., Skelton, B. W., & Steer, J. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601526 · Cited by 260
Copper Compounds in Cancer Chemotherapy
Ruiz-Azuara, L., & E. Bravo-Gomez, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793213751 · Cited by 253
Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Nowak-Sliwinska, P., van Beijnum, J. R., Casini, A., Nazarov, A. A., Wagnières, G., van den Bergh, H., Dyson, P. J., & Griffioen, A. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002074 · Cited by 248
Schuh, E., Pflüger, C., Citta, A., Folda, A., Rigobello, M. P., Bindoli, A., Casini, A., & Mohr, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300428v · Cited by 246
Photoactivatable Platinum Complexes
Bednarski, P. J., Mackay, F. S., & Sadler, P. J. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314053 · Cited by 244
McKeage, M. J., Maharaj, L., & Berners-Price, S. J. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00048-6 · Cited by 243
Copper in Medicine: Homeostasis, Chelation Therapy and Antitumor Drug Design
Wang, T., & Guo, Z. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776055742 · Cited by 233
Metal complexes in medicine with a focus on enzyme inhibition
Che, C.-M., & Siu, F.-M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.11.015 · Cited by 224
Hindi, K. M., Siciliano, T. J., Durmus, S., Panzner, M. J., Medvetz, D. A., Reddy, D. V., Hogue, L. A., Hovis, C. E., Hilliard, J. K., Mallet, R. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0708679 · Cited by 218
Organometallic Compounds: An Opportunity for Chemical Biology?
Patra, M., & Gasser, G. (2012) · ChemBioChem · doi:10.1002/cbic.201200159 · Cited by 213
Undressing of Phosphine Gold( I ) Complexes as Irreversible Inhibitors of Human Disulfide Reductases
Urig, S., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C., Tóth, K., Davioud‐Charvet, E., & Becker, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502756 · Cited by 206
Kelland, L. R., Sharp, S. Y., O’Neill, C. F., Raynaud, F. I., Beale, P. J., & Judson, I. R. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00141-5 · Cited by 206
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Casini, A., & Messori, L. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611798040732 · Cited by 196
Casini, A., Cinellu, M. A., Minghetti, G., Gabbiani, C., Coronnello, M., Mini, E., & Messori, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060436a · Cited by 194
On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
Meyer, A., Bagowski, C. P., Kokoschka, M., Stefanopoulou, M., Alborzinia, H., Can, S., Vlecken, D. H., Sheldrick, W. S., Wölfl, S., & Ott, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202939 · Cited by 187
Rackham, O., Nichols, S. J., Leedman, P. J., Berners-Price, S. J., & Filipovska, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.022 · Cited by 186
Wai-Yin Sun, R., Lok-Fung Chow, A., Li, X.-H., Yan, J. J., Sin-Yin Chui, S., & Che, C.-M. (2011) · Chemical Science · doi:10.1039/c0sc00593b · Cited by 181
Cyclometalated gold(iii) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons
Yan, J. J., Chow, A. L.-F., Leung, C.-H., Sun, R. W.-Y., Ma, D.-L., & Che, C.-M. (2010) · Chemical Communications · doi:10.1039/c001216e · Cited by 179
Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
Hartinger, C., Nazarov, A., Ashraf, S., Dyson, P., & Keppler, B. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785908978 · Cited by 167
Leid, J. G., Ditto, A. J., Knapp, A., Shah, P. N., Wright, B. D., Blust, R., Christensen, L., Clemons, C. B., Wilber, J. P., Young, G. W., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr408 · Cited by 167
Platinum anticancer drugs. From serendipity to rational design
Monneret, C. (2011) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2011.10.001 · Cited by 161
Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
Wang, X., & Guo, Z. (2008) · Dalton Trans. · doi:10.1039/b715903j · Cited by 160
Metal complexes for DNA-mediated charge transport
Barton, J. K., Olmon, E. D., & Sontz, P. A. (2010) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2010.09.002 · Cited by 154
Metal complexes of maltol and close analogues in medicinal inorganic chemistry
Thompson, K. H., Barta, C. A., & Orvig, C. (2006) · Chemical Society Reviews · doi:10.1039/b416256k · Cited by 153
Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151
Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA
Mendes, F., Groessl, M., Nazarov, A. A., Tsybin, Y. O., Sava, G., Santos, I., Dyson, P. J., & Casini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000135 · Cited by 151
Milacic, V., & Dou, Q. P. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.01.032 · Cited by 149
Stable Anticancer Gold(III)–Porphyrin Complexes: Effects of Porphyrin Structure
Sun, R. W., Li, C. K.-L., Ma, D., Yan, J. J., Lok, C., Leung, C., Zhu, N., & Che, C. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902741 · Cited by 149
Drewry, J. A., & Gunning, P. T. (2010) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2010.10.018 · Cited by 147
Wang, C., Shih, W., Chang, H. C., Kuo, Y., Hung, W., Ong, T., & Li, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101096x · Cited by 143
Eloy, L., Jarrousse, A., Teyssot, M., Gautier, A., Morel, L., Jolivalt, C., Cresteil, T., & Roland, S. (2012) · ChemMedChem · doi:10.1002/cmdc.201200055 · Cited by 139
Copper, Gold and Silver Compounds as Potential New Anti-Tumor Metallodrugs
Tan, S. J., Yan, Y. K., Lee, P. P. F., & Lim, K. H. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.234 · Cited by 136
Lemke, J., Pinto, A. V., Niehoff, P., Vasylyeva, V., & Metzler‐Nolte, N. (2009) · Dalton Transactions · doi:10.1039/b906140a · Cited by 130
Barry, N. P. E., & Sadler, P. J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15300a · Cited by 129
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes
Bhabak, K. P., Bhuyan, B. J., & Mugesh, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01057j · Cited by 127
Rackham, O., Shearwood, A.-M. J., Thyer, R. T., McNamara, E. L., Davies, S. M. K., Callus, B. A., Miranda‐Vizuete, A., Berners‐Price, S. J., Cheng, Q., Arnér, E. S. J., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.015 · Cited by 126
Cisplatin-associated neurotoxicity: can it be prevented?
Alberts, D. S., & Noel, J. K. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199506000-00003 · Cited by 126
Vergara, E., Casini, A., Sorrentino, F., Zava, O., Cerrada, E., Rigobello, M. P., Bindoli, A., Laguna, M., & Dyson, P. J. (2009) · ChemMedChem · doi:10.1002/cmdc.200900370 · Cited by 125
Youngs, W. J., Knapp, A. R., Wagers, P. O., & Tessier, C. A. (2011) · Dalton Transactions · doi:10.1039/c1dt11100k · Cited by 112
Yan, K., Lok, C., Bierła, K., & Che, C. (2010) · Chemical Communications · doi:10.1039/c0cc01058h · Cited by 110
Gabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M. P., Bindoli, A., Cinellu, M. A., Pieraccini, G., Luigi Messori, A., & Casini, A. (2010) · MedChemComm · doi:10.1039/c0md00181c · Cited by 110
Sivaram, H., Tan, J., & Huynh, H. V. (2012) · Organometallics · doi:10.1021/om300444c · Cited by 106
Cytotoxicity of Gold(I) N‐Heterocyclic Carbene Complexes Assessed by Using Human Tumor Cell Lines
Weaver, J., Gaillard, S., Toye, C., Macpherson, S., Nolan, S. P., & Riches, A. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201100321 · Cited by 98
Optimization of cisplatin for the treatment of hormone dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.025 · Cited by 96
Self-citationNaphthalimide gold(i) phosphine complexes as anticancer metallodrugs
Bagowski, C. P., You, Y., Scheffler, H., Vlecken, D. H. W., Schmitz, D. J., & Ott, I. (2009) · Dalton Transactions · doi:10.1039/b912378d · Cited by 93
Gunatilleke, S. S., & Barrios, A. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060158f · Cited by 84
Karver, M. R., Krishnamurthy, D., Kulkarni, R. A., Bottini, N., & Barrios, A. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901220m · Cited by 79
Jellicoe, M. M., Nichols, S. J., Callus, B. A., Baker, M. V., Barnard, P. J., Berners‐Price, S. J., Whelan, J., Yeoh, G. C., & Filipovska, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn093 · Cited by 75
Synthesis and in vitro Efficacy Studies of Silver Carbene Complexes on Biosafety Level 3 Bacteria
Panzner, M. J., Deeraksa, A., Smith, A. P., Wright, B. D., Hindi, K. M., Kascatan-Nebioglu, A., Torres, A. G., Judy, B. M., Hovis, C. E., Hilliard, J. K., et al. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200801159 · Cited by 73
The Design of Gold-Based, Mitochondria-Targeted Chemotherapeutics
Berners‐Price, S. J., & Filipovska, A. (2008) · Australian Journal of Chemistry · doi:10.1071/ch08175 · Cited by 68
Metal-containing peptide nucleic acid conjugates
Gasser, G., Sosniak, A. M., & Metzler‐Nolte, N. (2011) · Dalton Transactions · doi:10.1039/c0dt01706j · Cited by 67
Medicinal Organometallic Chemistry
Jaouen, G., & Dyson, P. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045047-4/00173-4 · Cited by 62
Design of nickel chelates of tetradentate N-heterocyclic carbenes with subdued cytotoxicity
Ray, S., Asthana, J., Tanski, J. M., Shaikh, M. M., Panda, D., & Ghosh, P. (2009) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2009.03.036 · Cited by 61
A water soluble CuI–NHC for CuAAC ligation of unprotected peptides under open air conditions
Gaulier, C., Hospital, A., Légeret, B., Delmas, A. F., Aucagne, V., Cisnetti, F., & Gautier, A. (2012) · Chemical Communications · doi:10.1039/c2cc30515a · Cited by 61
Reversible DNA Condensation Induced by a Tetranuclear Nickel(II) Complex
Dong, X.-D., Wang, X., He, Y., Yu, Z., Lin, M., Zhang, C., Wang, J., Song, Y., Zhang, Y., Liu, Z., et al. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001457 · Cited by 44
Optimization of cisplatin for the treatment of hormone-dependent tumoral diseases
Gust, R., Beck, W., Jaouen, G., & Schönenberger, H. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.029 · Cited by 44
Self-citationGroß, A., Hüsken, N., Schur, J., Raszeja, L. J., Ott, I., & Metzler‐Nolte, N. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200692g · Cited by 41
Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase
Karver, M. R., Krishnamurthy, D., Bottini, N., & Barrios, A. M. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.12.012 · Cited by 29
Liang, X., Campopiano, D. J., & Sadler, P. J. (2007) · Chemical Society Reviews · doi:10.1039/b617040b · Cited by 27
Chiellini, C., Casini, A., Cochet, O., Gabbiani, C., Ailhaud, G. P., Dani, C., Luigi Messori, A., & Amri, E. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890140 · Cited by 14
Cited by
Cyclic (Alkyl)(Amino)Carbenes (CAACs): Stable Carbenes on the Rise
Soleilhavoup, M., & Bertrand, G. (2015) · Accounts of Chemical Research · doi:10.1021/ar5003494 · Cited by 932
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
Kapdi, A. R., & Fairlamb, I. J. S. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00063c · Cited by 379
Zhukhovitskiy, A. V., MacLeod, M. J., & Johnson, J. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00220 · Cited by 363
Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs
Liu, W., & Gust, R. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.09.004 · Cited by 351
Self-citation
Metadata
- Authors
- Liu, W., & Gust, R.
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 42
- Issue
- 2
- Pages
- 755-773
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2029434164
- Cited by
- 762
- References
- 107
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.